Silo Pharma Inc. Common Stock (SILO)
Stock · NASDAQ · Health Care
$1.18as of 10/16/2026
Price chart
Active signals
SILO Signal Track Record
How signals performed across all stocks →What SILO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 21 | -5.5% | 33% | September 16, 2026 |
| Bollinger Band Breakout | 21 | -10.7% | 24% | July 8, 2026 |
| Volume Spike | 20 | -10.8% | 40% | September 30, 2026 |
| 200-Day Moving Average TouchActive now | 5 | -21.2% | 40% | April 24, 2026 |
| Any 20-session window (baseline) | -6.0% | 35% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SILO
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 3
- Website
- silopharma.com/
Fundamentals
- 1-day range
- $1.1$1.42
- Market cap
- $5.85M
- P/E (trailing)
- —
- P/E (forward)
- -1.75
- EPS (trailing)
- $-5.33
- Dividend yield
- —
- Beta
- -35.86
- Avg. volume
- 103.0K
How Silo Pharma Inc. Common Stock Makes Money
Where the revenue actually goes — FY2020 annual results
Source: 10-K filed Mar 29, 2021 · via SEC EDGAR / Finnhub
Silo Pharma Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SILOSilo Pharma Inc. Common Stock$1.18▼ 1.67%Market cap $5.85MP/E —$1.3$10.44
- NCNANuCana plc American Depositary Share$0.99▼ 2.94%Market cap $5.66MP/E 0.01$0.9484$6.1
- PULMPulmatrix Inc. Common Stock$1.36▼ 3.55%Market cap $6.06MP/E —$1.16$5.24
- GELSGelteq Limited Ordinary Shares$0.446▲ 3.48%Market cap $6.15MP/E —$0.387$2.01
- CURXCuranex Pharmaceuticals Inc Common Stock$4.62▼ 4.35%Market cap $5.53MP/E —$3.58$16.94
- APVOAptevo Therapeutics Inc. Common Stock$1.62▼ 4.71%Market cap $6.18MP/E 0.00$1.37$30.06
- HCWBHCW Biologics Inc. Common Stock$1.24▲ 0.81%Market cap $6.19MP/E —$1.14$27.3
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SILO Silo Pharma Inc. Common Stock | $5.85M | — | $1.18 | ▼ 1.67% | $1.3$10.44 |
| NCNA NuCana plc American Depositary Share | $5.66M | 0.01 | $0.99 | ▼ 2.94% | $0.9484$6.1 |
| PULM Pulmatrix Inc. Common Stock | $6.06M | — | $1.36 | ▼ 3.55% | $1.16$5.24 |
| GELS Gelteq Limited Ordinary Shares | $6.15M | — | $0.446 | ▲ 3.48% | $0.387$2.01 |
| CURX Curanex Pharmaceuticals Inc Common Stock | $5.53M | — | $4.62 | ▼ 4.35% | $3.58$16.94 |
| APVO Aptevo Therapeutics Inc. Common Stock | $6.18M | 0.00 | $1.62 | ▼ 4.71% | $1.37$30.06 |
| HCWB HCW Biologics Inc. Common Stock | $6.19M | — | $1.24 | ▲ 0.81% | $1.14$27.3 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Silo Pharma expands QwikAgents AI platform with new client
Silo Pharma’s subsidiary QwikAgents has added a new client to its AI agent platform. The update lets clients supply their own Nvidia API keys and introduces the Hermes Agent Runtime. The company was also listed among 12 health‑care stocks that moved in Friday’s after‑market session. The shares are trading near the lower end of their 52‑week range and are close to a support level of $5.81.
Silo Pharma expands QwikAgents AI platform with new client. Silo Pharma’s subsidiary QwikAgents has added a new client to its AI agent platform. The update lets clients supply their own Nvidia API keys and introduces the Hermes Agent Runtime. The company was also listed among 12 health‑care stocks that moved in Friday’s after‑market session. The shares are trading near the lower end of their 52‑week range and are close to a support level of $5.81.